Maccura Financial Statements From 2010 to 2024

Stocks . China . 
Stock . Maccura Biotechnology Co
300463 Stock   14.20  0.17  1.21%   
Maccura Biotechnology financial statements provide useful quarterly and yearly information to potential Maccura Biotechnology Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Maccura Biotechnology financial statements helps investors assess Maccura Biotechnology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Maccura Biotechnology's valuation are summarized below:
Gross Profit
2 B
Profit Margin
0.1192
Market Capitalization
8.6 B
Enterprise Value Revenue
3.0773
Revenue
2.7 B
We have found seventy-nine available fundamental ratios for Maccura Biotechnology, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Maccura Biotechnology last-minute market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Maccura Biotechnology Total Revenue

2.47 Billion

Check Maccura Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maccura Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 28.5 M, Selling General Administrative of 478.8 M or Total Revenue of 2.5 B, as well as many indicators such as . Maccura financial statements analysis is a perfect complement when working with Maccura Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Maccura Biotechnology Technical models . Check out the analysis of Maccura Biotechnology Correlation against competitors.

Maccura Biotechnology Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.4 B8.1 B4 B
Slightly volatile
Other Current Liabilities9.5 M10 M104.2 M
Pretty Stable
Total Current Liabilities1.1 B1.1 B839.8 M
Slightly volatile
Total Stockholder Equity3.8 B6.4 B2.7 B
Slightly volatile
Other Liabilities299.5 M285.2 M109.9 M
Slightly volatile
Retained Earnings2.5 B3.8 B1.8 B
Slightly volatile
Accounts Payable244.9 M365.8 M174.2 M
Slightly volatile
Cash487.8 M836 M375.5 M
Slightly volatile
Other Assets414 M394.3 M166 M
Slightly volatile
Long Term Debt240.5 M162.5 M189.1 M
Slightly volatile
Net Receivables1.6 B1.8 B1.2 B
Slightly volatile
Inventory775.1 M907.5 M572.5 M
Slightly volatile
Other Current Assets175.1 M112.6 M129 M
Slightly volatile
Total Liabilities1.5 B1.5 B1.1 B
Slightly volatile
Intangible Assets441.8 M420.8 M159.8 M
Slightly volatile
Common Stock524.6 M704.3 M407.7 M
Slightly volatile
Property Plant Equipment1.5 B2.9 B1.2 B
Slightly volatile
Net Tangible Assets3.5 B6.8 B3.1 B
Slightly volatile
Short Term Investments326.1 M311.1 M547.9 M
Slightly volatile
Deferred Long Term Liabilities72.7 M130.4 M50.9 M
Slightly volatile
Long Term Investments31.9 M34.5 M28.8 M
Slightly volatile
Short and Long Term Debt137.4 M144.6 M344.6 M
Slightly volatile
Total Current Assets3.6 B4.2 B2.8 B
Slightly volatile
Short Term Debt1.4 B1.4 B635.8 M
Slightly volatile
Non Current Assets Total2.5 B3.9 B1.8 B
Slightly volatile
Non Currrent Assets Other3.5 M3.7 M448.1 M
Slightly volatile
Good Will175.3 M166.9 M41.7 M
Slightly volatile
Non Current Liabilities Total416.6 M387.2 M239.3 M
Slightly volatile
Net Debt476 M285.7 M422 M
Pretty Stable
Common Stock Shares Outstanding630.5 M704.3 M576 M
Slightly volatile
Net Invested Capital5.6 B6.7 B4.2 B
Slightly volatile
Non Current Liabilities Other3.3 M3.4 M95.2 M
Slightly volatile
Net Working Capital2.6 B3.1 B1.9 B
Slightly volatile
Capital Stock633.3 M704.3 M576.2 M
Slightly volatile
Property Plant And Equipment Net2.4 B2.9 B1.8 B
Slightly volatile
Property Plant And Equipment Gross3 B3.9 B2.3 B
Slightly volatile
Capital Lease Obligations12.9 M13 M17.9 M
Slightly volatile
Other Stockholder Equity16.2 M26.8 M14.2 M
Slightly volatile

Maccura Biotechnology Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative478.8 M714.6 M396.7 M
Slightly volatile
Total Revenue2.5 B2.9 B2 B
Slightly volatile
Operating Income651 M451.5 M544.6 M
Slightly volatile
Cost Of Revenue1.1 B1.3 B925.1 M
Slightly volatile
Income Before Tax593.2 M305.4 M497.6 M
Slightly volatile
Net Income Applicable To Common Shares494.3 M814.1 M437.8 M
Slightly volatile
Net Income481.8 M312.6 M403.6 M
Slightly volatile
Income Tax Expense102.7 M100.8 M87.5 M
Slightly volatile
Research Development170.3 M324.2 M126.3 M
Slightly volatile
Gross Profit1.6 B1.6 B1.2 B
Slightly volatile
Other Operating Expenses3.1 M3.3 M13.1 M
Pretty Stable
Net Income From Continuing Ops594.8 M304.7 M447.7 M
Slightly volatile
EBIT802.6 M1 B611.1 M
Slightly volatile
Total Operating Expenses2.2 B2.4 B1.6 B
Slightly volatile
Tax Provision655.4 K689.9 K84 M
Very volatile
Interest Income5.5 M10 M3.4 M
Slightly volatile
EBITDA1.1 B1.3 B853.9 M
Slightly volatile
Reconciled Depreciation220.3 M313.1 M154.7 M
Slightly volatile

Maccura Biotechnology Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Income481.8 M312.6 M403.6 M
Slightly volatile
Dividends Paid148.2 M244.6 M112.4 M
Slightly volatile
Total Cash From Operating Activities592.4 M901.5 M429.2 M
Slightly volatile
Other Cashflows From Investing Activities5.7 M10.8 M5.5 M
Pretty Stable
Depreciation186.5 M313.1 M131.8 M
Slightly volatile
Change To Netincome107.9 M128.1 M72.7 M
Slightly volatile
End Period Cash Flow527.5 M811.4 M332.6 M
Slightly volatile
Begin Period Cash Flow475.4 M564.3 M282 M
Slightly volatile
Other Non Cash Items55.5 M37.2 M35.1 M
Slightly volatile

About Maccura Biotechnology Financial Statements

Maccura Biotechnology stakeholders use historical fundamental indicators, such as Maccura Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Maccura Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Maccura Biotechnology's assets and liabilities are reflected in the revenues and expenses on Maccura Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Maccura Biotechnology Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.9 B2.5 B
Cost Of Revenue1.3 B1.1 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in Maccura Stock

Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY